Efficacy of a Combined Natural Extract of Turmeric ( Curcuma longa ) and Liquorice ( Glycyrrhiza uralensis ) Against Viral Haemorrhagic Septicaemia Virus in Olive Flounders ( Paralichthys olivaceus )
Journal of Fish Diseases · 2026
DOI: 10.1111/jfd.70002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fish Diseases, 2026. Verfasst von Su-Mi Shin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aqualife Medicine, Chonnam National University, Republic of Korea. Hauptthemen laut MEDLINE: Novirhabdovirus, Plant Extracts, Hemorrhagic Septicemia, Viral, Curcuma. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Institute of Marine Science and Technology Promotion.
Abstract (Originalsprache)
Viral haemorrhagic septicaemia virus (VHSV) causes a high mortality rate in cultured olive flounder, and effective treatment for VHSV infection is urgently required. Turmeric ( Curcuma longa ) and liquorice ( Glycyrrhiza uralensis ) are well‐known medicinal plants with a variety of biological activities. Turmeric and liquorice extract combination (TLex), containing 12 g glycyrrhizin and 0.72 g curcumin per litre, exhibited low cytotoxicity (CC 50 : 7903.08 ± 6.26 μg/mL) and potent antiviral activity (EC 50 : 149.4 ± 2.34 μg/mL) in hirame natural embryo (HINAE) cells. Plaque reduction assays indicated that post‐exposure treatment was most effective, with antiviral efficacy increasing over time. Additionally, TLex at 133.4 μg/mL upregulated antiviral genes (Mx, ISG15, IRF3 and IRF8) at 24 h. Oral administration of TLex conferred substantial protection against VHSV. In in vivo trial I, fish receiving TLex at 3.2, 108, and 207.9 μL/fish/day exhibited relative percent survival (RPS) rates of 42.9%–50% at 2 weeks and 35.7%–42.9% at 6 weeks. In in vivo trial II, the minimum effective dose was 1.0 μL/fish/day, yielding RPS rates of 23.5%–25% at 2 weeks and 30.0%–33.3% at 5 weeks, whereas lower concentrations (0.1 and 0.5 μL/fish/day) provided minimal or no protection (5%–20% RPS). Field trials with TLex (30 μL/g of feed weight) resulted in RPS rates of 25.0%–100% in VHSV‐challenged fish. These findings demonstrate that TLex is an effective antiviral agent for controlling VHSV infections in olive flounder farms, enhancing immune responses and exhibiting strong in vivo antiviral activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Aqualife Medicine, Chonnam National University, Republic of Korea.
- Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Republic of Korea.
- Department of Marine Production Management, Chonnam National University, Republic of Korea.
ORCID-Profile: Su-Mi Shin, Walimuni Randika Harshan Mendis, Taeho Kim, Sung-Ju Jung
Förderung
- Korea Institute of Marine Science and Technology Promotion
Zitieren
APA
Shin, S. M., Mendis, W. R. H., Kang, S. Y., Jeong, H. J., Kim, T., & Jung, S. J. (2026). Efficacy of a Combined Natural Extract of Turmeric ( Curcuma longa ) and Liquorice ( Glycyrrhiza uralensis ) Against Viral Haemorrhagic Septicaemia Virus in Olive Flounders ( Paralichthys olivaceus ). Journal of Fish Diseases. https://doi.org/10.1111/jfd.70002
Vancouver
Shin SM, Mendis WRH, Kang SY, Jeong HJ, Kim T, Jung SJ. Efficacy of a Combined Natural Extract of Turmeric ( Curcuma longa ) and Liquorice ( Glycyrrhiza uralensis ) Against Viral Haemorrhagic Septicaemia Virus in Olive Flounders ( Paralichthys olivaceus ). Journal of Fish Diseases. 2026. doi:10.1111/jfd.70002
BibTeX
@article{Shin2026,
author = {Shin, Su-Mi and Mendis, Walimuni Randika Harshan and Kang, So Young and Jeong, Hyung Jae and Kim, Taeho and Jung, Sung-Ju},
title = {Efficacy of a Combined Natural Extract of Turmeric ( Curcuma longa ) and Liquorice ( Glycyrrhiza uralensis ) Against Viral Haemorrhagic Septicaemia Virus in Olive Flounders ( Paralichthys olivaceus )},
journal = {Journal of Fish Diseases},
year = {2026},
doi = {10.1111/jfd.70002}
}
EUVIMED